Intense migraines secondary to percutaneous closure of atrial septal defects

Journal of Interventional Cardiology

Volumn 18, Issue 3, 2005, Pages 181-183

  Sharifi, Mohsen ^a   Dehghani, Majid ^b   Mehdipour, Mahshid ^b   Al Bustami, Omar ^b   Emrani, Farnaz ^b   Burks, James ^b  

^a Sunrise Cardiovascular Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; IBUPROFEN; PARACETAMOL; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; DEVICE; FEMALE; FLUOROSCOPY; HEART ATRIUM SEPTUM DEFECT; HEART RATE; HEPARINIZATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LUNG ARTERY PRESSURE; MALE; MIGRAINE; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; MIGRAINE WITHOUT AURA; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 21744452209     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.04068.x     Document Type: Article

References (15)

1. Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The PFO-ASA Study. Stroke 2002;33:706-711.
2. Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: A new migraine treatment? J Interv Cardiol 2003;16:39-42.
3. Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
4. Sztajzel R, Genoud D, Roth S, et al. Patent foramen ovale, a possible cause of symptomatic migraine: A study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002;13:102-106.
5. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24:1865-1873.
6. Di Tullio M, Sacco RL, Gopal A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
7. Masura J, Gavora P, Formanek A, et al. Transcatheter closure of secunduni atrial septal defects using the new self-centering amplatzer septal occluder: Initial human experience. Cathet Cardiovasc Diagn 1997;42:388-393.
8. The Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Second Edition. Cephalalgia 2004;24(Suppl 1):1-150.
9. Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-1692.
10. Welch KMA, Levine SR. Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol 1990;47:458-462.
11. Jorgensen HS, Jespersen HF, Nakayama H, et al. Headache in stroke: The Copenhagen stroke study. Neurology 1994;44:1793-1797.
12. Kitano A, Shimomura T, Takeshima T, et al. Increased 11- dehydrothromboxane B2 in migraine: Platelet hyperfunction in patients with migraine during headache-free period. Headache 1994;34:515-518.
13. Buring JE, Hebert P, Romero J, et al. Migraine and subsequent risk of stroke in the Physicians Health Study. Arch Neurol 1995;52:129-134.
14. Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999;52;1622-1625.
15. Rodes-Cabau J, Molina C, Serrano-Munuera C, et al. Migraine with aura related to the percutaneous closure of an atrial septal defect. Catheter Cardiovasc Interv 2003;60;540-542.